Related Experiment Video
Updated: Sep 30, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
[How does the completion of human genome project affect our possibilities to clarify pathogenesis of diseases?]
1Kansanterveyslaitos, molekyylilääketieteen osasto Helsingin yliopiston lääketieteellisen genetiikan laitos Department of Human Genetics, UCLA School of Medicine, Gonda Center, Los Angeles, California 90095-7088, USA. leena.peltonen@mednet.ucla.edu
No abstract available in PubMed .
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
CRISPR
Modern Molecular Taxonomy